Mesoblast’s (MESO) “Overweight” Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report published on Tuesday, Benzinga reports. Separately, StockNews.com downgraded Mesoblast from a hold rating to a sell rating in a research note on Wednesday, May 8th. Two investment analysts have rated the stock with a sell rating, three have […]

Leave a Reply

Your email address will not be published.

Previous post TD Securities Cuts Coveo Solutions (TSE:CVO) Price Target to C$12.00
Next post Shinhan Financial Group (NYSE:SHG) Downgraded to Hold at StockNews.com